PROCARE HEALTH
Empowering women at every stage of their life
Procare Health is a Spanish pharmaceutical laboratory with an international vocation specialized in women’s health. In our first decade of life, we have launched innovative products, formulated with bio-optimized ingredients of natural origin, that have revolutionized the quality of life of women around the world
Empowering women at every stage of their lives
Procare Health is a Spanish pharmaceutical laboratory with an international vocation specialized in women’s health. In our first decade of life, we have launched innovative products on the market, formulated with bio-optimized ingredients of natural origin, which have revolutionized the quality of life of women around the world
Papilocare®
Palomacare®
Palomacare® Crispatus
Herpecare®
Ciscare®
Ovosicare®
Gestacare®
Ironcare® Forte
Libicare® Meno
Idracare®
DCare® K2
Menocare®
Libicare® ONE
Libicare®
Dolocare® Flex
Dolocare® Forte
DCare® Forte
Pronolis® HD
Papilocare®
Papilocare®
Papilocare Inmunocaps®
Palomacare®
Palomacare®
Palomacare®
Palomacare®
Palomacare® Crispatus
Ovosicare®
Ovosicare® ProFIV
Gestacare®
Ironcare®
Ironcare® Forte
Libicare® Meno
Menocare®
Libicare® ONE
Libicare®
Idracare®
Dcare® Forte
Dcare® Forte
Dolocare® Flex
Dolocare® Forte
Pronolis® HD
Pronolis® HD
Pronolis® HD
PROCARE HEALTH
Biotech Investigation
We are scientists by definition and we are constantly seeking to improve our products, but also to study their effects. For this reason, we allocate up to 25% of our budget to R&D and carry out ambitious international clinical research studies
PROCARE HEALTH
Investigation Biotech
We are scientists by definition and we constantly seek to improve our products, but also to study their effects. For this reason, we allocate up to 25% of our budget to R&D and carry out ambitious international clinical research studies
INTERNACIONALIZACIÓN
Procare Health in the world
With little more than 10 years of life, we have established ourselves in different European countries and we have also managed to reach other continents. Our products are commercialized in more than 45 different countries, and we continue working to make them available in more than the 65 countries where we have reached distribution agreements (currently undergoing regulatory approval with local authorities).
INTERNACIONALIZATION
Procare Health in the world
With little more than 10 years of life, we have established ourselves in different European countries and we have also managed to reach other continents. Our products are commercialized in more than 45 different countries, and we continue working to make them available in more than the 65 countries where we have reached distribution agreements (currently undergoing regulatory approval with local authorities).
Press
From the press area, you can closely follow all the news about our company
New ovarian cancer drug could give women years of life in the form of a ‘therapeutic’ vaccine
Women who have ovarian cancer are to receive a new vaccine that experts hope could give them years of extra life. Survival rates for the disease, which claims more than 4,000 lives a year in Britain…
Global Human Papillomavirus (HPV) Vaccine Market Could Exceed $12 Billion By 2027
The Fortune report projected that The global Human Papillomavirus (HPV) Vaccine market size was valued at USD 3.80 billion in 2019 and is projected to
BioVaxys Technology and Procare Health Announce Broad CoDevelopment for Cancer and Viral Vaccines
Under the terms of the agreement, which was executed on February 9th, 2021, the companies will jointly conduct a Phase I Clinical Study of BVX-0918A in Spain, BioVaxys’ autologous haptenized protein vaccine for late-stage ovarian cancer…
